Steris PLC
STE: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$254.00 | Xggdknj | Wsypppwv |
Narrow-Moat Steris Sees Sequential Gains in Fiscal Second Quarter; Shares Still Fairly Priced
Narrow-moat Steris reported improved fiscal 2021 second-quarter results. While revenue and earnings increased compared with the year-ago period, the firm’s growth trajectory continues to be slowed by the ongoing COVID-19 pandemic. We are maintaining our $175 fair value estimate and believe the shares are fairly valued.